Biosystems Immunolab Zrt. (BSI) is an in-vitro diagnostics R&D company.
BSI deploys a unique and protected protein epitome profiling technology platform for the discovery and development of disease specific plasma protein epitope panels (multivariate index assays). The diagnostics are enabled to run on popular validated protein array and ELISA platforms. (see news)
To speed discovery to market time, we license or sell our Dx candidates to industrial partners present on the global market. In parallel, BSI offers special laboratory services using its mAb proteomics technologies.
